diff --git a/knowledge/large_corpus.xbel.gz b/knowledge/large_corpus.xbel.gz index 010e858..12e0116 100644 Binary files a/knowledge/large_corpus.xbel.gz and b/knowledge/large_corpus.xbel.gz differ diff --git a/knowledge/small_corpus.xbel b/knowledge/small_corpus.xbel index 51077cf..b6f2f84 100644 --- a/knowledge/small_corpus.xbel +++ b/knowledge/small_corpus.xbel @@ -2958,8 +2958,8 @@ complex (Figure 3 and Box 1). HIF1A - P H + P @@ -9747,43 +9747,6 @@ in the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant. "Group 5" - - - Review - - 12444918 - The Biochemical journal - - - Houslay MD - Adams DR - - - Originally identified by high-throughput screening of small molecules against C-Raf -kinase, sorafenib was found to be a potent competitive inhibitor of ATP binding -in the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant. - - - - - ADRB2 - - - - - - - ADRB2 - - - PDE4 Family - - - ARRB Family - - - - Review